RXST vs RPID

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

RXST

54.9
AI Score
VS
RXST Wins

RPID

37.9
AI Score

Investment Advisor Scores

RXST

55score
Recommendation
HOLD

RPID

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric RXST RPID Winner
Forward P/E 116.2791 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.3% 10.9% RPID
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 54.9/100 37.9/100 RXST
Profit Margin -36.8% -145.6% RXST
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY RXST

Relative Price Performance (Last 90 Days)

RXST 1M: -32.0% · 3M: -15.3% RPID 1M: -38.6% · 3M: -46.5%

Current Technical Phase

RXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.4 · Price: $4.75

RPID

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.2%), weak momentum, RSI 15

RSI (14): 15.4 · Price: $0.92

Fundamentals Snapshot

Metric RXST RPID
Market Cap — —
Forward P/E -6.8 -1.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.1%
Operating Margin -0.4% -1.5%
EPS -1.14 -1.11
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.